Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PON1 | P27169 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL205339 | 0.98 | — | — | |
| Bromide SCHEMBL2230104 | 0.96 | SMN1; SMN2 (0.47) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| Bromide SCHEMBL21777067 | 0.96 | SMN1; SMN2 (0.43) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| Water SCHEMBL5809030 | 0.96 | SMN1; SMN2 (0.43) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL59757 | 0.96 | SMN1; SMN2 (0.43) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| Fluoride Ion SCHEMBL4200937 | 0.96 | SMN1; SMN2 (0.43) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| Ammonia Solution, Strong SCHEMBL28942113 | 0.96 | SMN1; SMN2 (0.43) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL27711491 | 0.94 | SMN1; SMN2 (0.42) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL31139327 | 0.90 | SMN1; SMN2 (0.40) | MEN1KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL1947169 | 0.90 | SMN1; SMN2 (0.40) | MEN1KMT2ASMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3470493-B1 | COMPOSITIONS COMPRISING LATENT HEAT STORAGE MATERIALS | PHASE CHANGE ENERGY SOLUTIONS INC (US) | 2024-05-15 | — | — | EP | claimed |
| WO-2024081696-A2 | COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| CN-114460224-A | Method for screening ionic liquid regenerated solvent based on thermodynamic property | 新疆大学 | 2022-05-10 | — | — | CN | claimed |
| US-10907080-B2 | Compositions comprising latent heat storage materials and methods of making the same | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2021-02-02 | — | — | US | claimed |
| EP-3740543-A1 | INCREASED SATURATION OF ICE MELTING COMPOSITIONS AND METHODS OF USE | BASF SE (DE) | 2020-11-25 | — | — | EP | claimed |
| US-20200339851-A1 | INCREASED SATURATION OF ICE MELTING COMPOSITIONS AND METHODS OF USE | BASF CORPORATION | 2020-10-29 | — | — | US | claimed |
| US-10745604-B2 | Compositions comprising phase change materials and methods of making the same | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2020-08-18 | — | — | US | claimed |
| CN-111511871-A | Enhanced ice melting composition saturation and methods of use | 巴斯夫欧洲公司 | 2020-08-07 | — | — | CN | claimed |
| EP-3372653-B1 | COMPOSITIONS COMPRISING PHASE CHANGE MATERIALS | PHASE CHANGE ENERGY SOLUTIONS INC (US) | 2020-07-29 | — | — | EP | claimed |
| WO-2019141568-A1 | INCREASED SATURATION OF ICE MELTING COMPOSITIONS AND METHODS OF USE | BASF SE (DE) | 2019-07-25 | — | — | WO | claimed |
| US-20150274927-A1 | Inorganic Ionomers Made From Minerals | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2015-10-01 | — | — | US | claimed |
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-20140335698-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION (US) | 2014-11-13 | — | — | US | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20130292601-A1 | Additives for Dye-Sensitized Solar Cells | MERCK PATENT GMBH (DE) | 2013-11-07 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20120273044-A1 | ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL USING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-11-01 | — | — | US | claimed |
| US-20100154889-A1 | ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL USING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-06-24 | — | — | US | claimed |
| US-20100101644-A1 | ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL (DSSC) COMPRISING THE SAME | TRIPOD TECHNOLOGY CORPORATION (TW) | 2010-04-29 | — | — | US | claimed |
| US-4940554-A | Quaternary organic nitrogen heterocvclic compound for pretreatment of base materials for chemical metallization | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100154889-A1 | ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL USING THE SAME | HCN4, HCN2, HCN3 | MEN1 899/4885KMT2A 2739/4885SMN1; SMN2 3271/4885 |
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | MEN1 1923/4885KMT2A 2453/4885SMN1; SMN2 4519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.